Stock Ratings / Health Care / OSUR / financials

INFU (76) ANIK (55) TMCI (41) CLPT (34) ⌘ Pro Terminal →

OraSure Technologies Inc. (OSUR) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$4.08 -0.49% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $4.07

OraSure Technologies Inc. (OSUR) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $281.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $4.07 (-0.28%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-11.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OSUR)Realized 20D OHLCV Swing Band: ±10.6%

Deterministic 5-Pillar Attribution (32/100 Composite)

🔍 WHY OSUR SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+10/20 pts (31% of score)

FRED Regime × Technicals: 80% of 52W Range • RSI-14 at 52 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (28% of score)

20D Institutional Volume Accumulation (±10.6% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$3.90-7.4% Next Q

Q2 (-2Q)

Grade E$3.61+14.4% Next Q

Q3 (-1Q)

Grade E$4.13-1.2% Next Q

Current

Grade E$4.08-9.2% Hist 90D α

Trajectory: E (24) → E (32)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a OSUR Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While OSUR currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.76) and Max Pain ($4.28) forces dealer call-delta covering toward $4.81.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OSUR• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “OSUR Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 32%NO 68%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How OSUR Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $405.5M

FY24

Rev $185.8M

FY25

Rev $115.0M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$115.0M	41.9%	-62.6%	-$68.7M	-$53.2M	-40.2%
FY 2024	$185.8M	42.7%	-15.2%	-$19.5M	$23.6M	-15.7%
FY 2023	$405.5M	41.9%	8.1%	$53.7M	$141.6M	-35%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring OSUR)

✓Walkthrough of OSUR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

OSUR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +34.21%📐 HORIZONTAL RANGE

2026-10-30O $4.07H $4.10L $3.92C $4.08VOL 609.4K

RES: $4.39SUP: $2.59SMA50: $3.76SMA200: $3.51

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OSUR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 OSUR Butterfly Map → + Track OSUR →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -38.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on OSUR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for OSUR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for OSUR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OSUR)

Health Care Rank #892 of 1016 ⚔️ INFU vs OSUR Full Matrix →

1. Head-to-Head Health Care Peer Comparison (OSUR vs. INFU, ANIK, TMCI, CLPT)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, OraSure Technologies Inc. (OSUR) ranks #892 by composite RQD confidence (32/100, grade E) and #527 by equity capitalization ($281.4M). Within this direct 5-issuer industry benchmark cohort, INFU leads on earnings valuation at 43.4x trailing P/E, while INFU leads on capital efficiency and profitability with 12.8% ROIC and 56.0% gross margin. INFU currently holds the highest overall quantitative score in the immediate peer group at 76/100 (B+) compared with OSUR at 32/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
OSUR ACTIVE OraSure Technologies Inc.	E	32/100	—	41.9%	-35.0%	-0.49%	$281.4M	Benchmark Subject
INFU InfuSystems Holdings Inc.	B+	76/100	43.4x	56.0%	12.8%	+0.91%	$287.8M	/infu-vs-osur →
ANIK Anika Therapeutics Inc.	D+	55/100	—	56.6%	-10.2%	+1.11%	$291.6M	/anik-vs-osur →
TMCI Treace Medical Concepts Inc.	D-	41/100	—	79.8%	-32.4%	+4.76%	$329.1M	/tmci-vs-osur →
CLPT ClearPoint Neuro Inc.	E	34/100	—	61.4%	-35.0%	+1.23%	$342.7M	/clpt-vs-osur →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001116463

In its most recent audited fiscal period (FY2025, filed 2025-12-31), OraSure Technologies Inc. (OSUR) reported GAAP revenue of $115.0M (-38.1% vs. FY2024 revenue of $185.8M , and -71.6% cumulative change since FY2023) , GAAP net income of -$68.7M, operating cash flow of -$49.0M, and free cash flow of -$53.2M (-325.7% YoY). On the balance sheet, OSUR closed FY2025 with $403.2M in total assets against $0 in total debt (Altman Z-Score: 2.47, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$115.0M	-$68.7M	-$49.0M	-$53.2M	$403.2M	—
FY2024 (FY)	2024-12-31	$185.8M	-$19.5M	$27.4M	$23.6M	$479.7M	—
FY2023 (FY)	2023-12-31	$405.5M	$53.7M	$141.6M	$141.6M	—	—

3. OSUR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OSUR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, OraSure Technologies Inc. (NASDAQ: OSUR) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $4.08 (-0.49% 1D, market cap $281.4M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 4/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, OSUR ranks #892 in composite RQD confidence.

How does OSUR compare to INFU and ANIK in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), OSUR carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 41.9%, and ROIC of -35.0%. By comparison, INFU (InfuSystems Holdings Inc.) holds a B+ grade (76/100 RQD, P/E 43.4x, ROIC 12.8%, cap $287.8M) and ANIK (Anika Therapeutics Inc.) posts a D+ grade (55/100 RQD, P/E N/A, ROIC -10.2%, cap $291.6M). Among the 5-stock peer group, INFU leads on earnings multiple (43.4x) while INFU leads on capital efficiency (12.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for OSUR?

Per OSUR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001116463), OraSure Technologies Inc. generated $115.0M in revenue (-38.1% YoY), -$68.7M in net income, and -$53.2M in free cash flow against $403.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is OSUR trading relative to its 50-day, 200-day, and 52-week technical levels?

OSUR last traded at $4.08 (-0.49% on volume of 1,232,986 shares), positioning the stock +8.51% above its 50-day simple moving average ($3.76) and +16.24% above its 200-day simple moving average ($3.51). Across its 52-week range of $2.08 to $4.58, OSUR sits at the 80.0% percentile with a 14-day RSI of 52.0 (NEUTRAL RANGE) and an implied next-earnings move of ±10.6% ($3.65 to $4.51).